Behbahani Ali
- SEC CIK
- 0001613867
In the past year, 2 open-market sale filings worth $807.4K and no purchases.
Current role at each company
- CRSP CRISPR Therapeutics AGDirectoras of Sep 21, 2026
- BDTX Black Diamond Therapeutics, Inc.Directoras of Sep 21, 2026
- GLUE Monte Rosa Therapeutics, Inc.Directoras of Jul 6, 2026
- KRRO Korro Bio, Inc.Directoras of Jun 11, 2026
- NKTX Nkarta, Inc.Directoras of Jun 11, 2026
Show 15 more companies
- ACLX Arcellx, Inc.Directoras of Apr 28, 2026
- SGP SpyGlass Pharma, Inc.Director, 10% Owneras of Feb 11, 2026
- NEUE NeueHealth, Inc.Director, 10% Owneras of Oct 6, 2025
- ADAPY Adaptimmune Therapeutics PLCDirectoras of Aug 19, 2025
- MRKR Marker Therapeutics, Inc.10% Owneras of Dec 23, 2024
- MBX MBX Biosciences, Inc.10% Owneras of Sep 17, 2024
- CVRX CVRx, Inc.Directoras of Jun 7, 2024
- SVRA Savara Inc10% Owneras of Jul 19, 2023
- MIRM Mirum Pharmaceuticals, Inc.10% Owneras of Jun 15, 2023
- OYST Oyster Point Pharma, Inc.Directoras of Jan 4, 2023
- AKUS Akouos, Inc.10% Owneras of Dec 2, 2022
- UTRS Minerva Surgical IncDirectoras of Jun 14, 2022
- GNCA Genocea Biosciences, Inc.Director, 10% Owneras of May 26, 2022
- TRVI Trevi Therapeutics, Inc.10% Owneras of Apr 13, 2022
- MTCR Metacrine, Inc.10% Owneras of Dec 27, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $807.4K
- 2 filings
- Net
- −$807.4K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Behbahani Ali as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRSP CRISPR Therapeutics AG
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 (view filing)6:40 PM ET | Sep 17 | 4 days | Behbahani AliDirector | SSale | −13.7K | $57.09 | −$780.9K | −45.1%16.6K after |
SGP SpyGlass Pharma, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Behbahani AliDirector, 10% Owner | PPurchase | +937.5K | $16.00 | +$15.0M | +18.4%6.04M after | Duplicate filing |
NEUE NeueHealth, Inc.
Director, 10% Owner9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 (view filing)5:52 PM ET | Oct 2 | 4 days | Behbahani AliDirector, 10% Owner | SSale | −3.92K | $6.75 | −$26.4K | −0.2%2.26M after | 4 lots |
| Oct 3, 2024 (view filing) | Oct 1 | 2 days | Behbahani Ali10% Owner | PPurchase | +309.3K | – | – | –556.8K after | Derivative3 lots |
| Apr 10, 2024 (view filing) | Apr 8 | 2 days | Behbahani Ali10% Owner | PPurchase | +618.6K | – | – | –371.2K after | Derivative3 lots |
| Dec 21, 2023 (view filing) | Dec 19 | 2 days | Behbahani Ali10% Owner | PPurchase | +175.5K | – | – | –1.66M after | Derivative |
| Nov 2, 2023 (view filing) | Oct 31 | 2 days | Behbahani Ali10% Owner | PPurchase | +100.6K | – | – | –1.48M after | DerivativeDuplicate filing |
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | Behbahani Ali10% Owner | PPurchase | +552.3K | – | – | –1.38M after | Derivative |
| Aug 15, 2023 (view filing) | Aug 11 | 4 days | Behbahani Ali10% Owner | PPurchase | +828.4K | – | – | –828.4K after | Derivative |
| Oct 19, 2022 (view filing) | Oct 17 | 2 days | Behbahani Ali10% Owner | PPurchase | +97.2M | $1.42 | +$137.7M | –100.0K after | Derivative2 lots |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Behbahani Ali10% Owner | PPurchase | +44.0M | $4.55 | +$200.0M | –125.0K after | Derivative2 lotsDuplicate filing |
ADAPY Adaptimmune Therapeutics PLC
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 (view filing)7:07 PM ET | Aug 15-18 | 4 days | Behbahani AliDirector | SSaleOrdinary Shares with a nominal value of 0.001 GBP per share | −19.5M | $0.0118 | −$229.2K | −100.0%0 after | 2 lots |
MRKR Marker Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 (view filing)4:40 PM ET | Dec 23 | Same day | Sandell Scott D and 9 others10% Owner | PPurchase | +554.3K | $3.20 | +$1.77M | +51.7%1.63M after |
MBX MBX Biosciences, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 (view filing) | Sep 16 | 1 day | Behbahani Ali10% Owner | PPurchase | +500.0K | $16.00 | +$8.00M | +16.1%3.61M after | Duplicate filing |
SVRA Savara Inc
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 (view filing) | Jul 17 | 2 days | Behbahani Ali10% Owner | PPurchase | +333.3K | $3.00 | +$1.00M | +1.4%24.5M after | Duplicate filing |
BDTX Black Diamond Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2023 (view filing) | Jul 5 | 1 day | Behbahani AliDirector | PPurchase | +1.00M | $5.00 | +$5.00M | +29.0%4.45M after |
GNCA Genocea Biosciences, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2022 (view filing)6:19 PM ET | May 24-25 | 2 days | Behbahani AliDirector, 10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
TRVI Trevi Therapeutics, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Behbahani Ali10% Owner | PPurchase | +3.58M | $1.90 | +$6.80M | New position948.9K after | 2 lots |
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Behbahani Ali10% Owner | PPurchase | +3.00M | $1.90 | +$5.70M | –3.00M after | Derivative |
| Oct 19, 2021 (view filing) | Oct 18 | 1 day | Behbahani Ali10% Owner | PPurchase | +1.85M | – | – | +31.2%7.79M after | Duplicate filing |
| Oct 19, 2021 (view filing) | Oct 18 | 1 day | Behbahani Ali10% Owner | PPurchase | +3.70M | – | – | –1.85M after | Derivative2 lotsDuplicate filing |
MTCR Metacrine, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2021 (view filing)4:41 PM ET | Dec 10-22 | 17 daysLate | Behbahani Ali10% Owner | SSale | −497.3K | $0.9944 | −$494.5K | −16.2%2.56M after | 3 lotsDuplicate filing |